Concepedia

Publication | Closed Access

3300 A phase 1b/2 study of ribociclib (LEE011; CDK4/6 inhibitor) in combination with binimetinib (MEK162; MEK inhibitor) in patients with NRAS-mutant melanoma

DOI

20

Citations

0

References

2015

Year

C. van Herpen, Michael A. Postow, Matteo S. Carlino, Halime Kalkavan, Amy Weise, R.N. Amaria, Fyfl de Vos, Richard D. Carvajal, A Matano, Suraj G. Bhansali,
European Journal of Cancer

No additional data available for this publication yet. Check back later!